JOVANA
Library Glossary Getting Started Three Levels Fields How it works Mission
Join the mission
All guides

Scaffold Hopping: New Frame, Same Handshake

Sometimes the problem is the whole core, not one group. Scaffold hopping replaces the central frame while keeping the pharmacophore in place — to escape patents, dodge liabilities, or open fresh chemistry.

Replacing the frame, not the features

Scaffold hopping is the boldest version of "keep the pharmacophore, change the chemistry." Instead of swapping one peripheral group, you replace the entire central scaffold — the ring system or linker that holds everything together — with a structurally distinct one, while keeping the pharmacophore features in the same 3D positions. Done right, the new molecule shakes the target's hand exactly as before, even though a chemist would never guess the two are related.

Why take such a big swing? Three common reasons: to design around a competitor's patent (a new scaffold can be a new chemical series), to escape a liability baked into the core itself rather than its substituents, and to open a different, often easier, synthetic route. A bonus is that a fresh scaffold sometimes improves druglikeness in ways no single substituent could.

How chemists hop

There is a spectrum from conservative to radical. Ring-opening and ring-closing, hetero-atom shuffling, and ring-system replacement are gentle hops. Topological or "shape-based" hops keep only the 3D feature arrangement and let the connecting atoms differ completely. The search engine is your pharmacophore model: define the essential features and their geometry, then ask which other frameworks can display them.

  1. Build the pharmacophore: from your actives, fix the essential features and the distances between them — this is the ligand-based anchor.
  2. Search for alternative scaffolds that can present those features in the same geometry — via shape/pharmacophore screening or de novo design.
  3. If a target structure exists, dock the candidate frames with docking and check the features still reach their partners (structure-based check).
  4. Synthesize a few representatives and test — a real hop is only confirmed when potency survives the move, not on screen.

Privileged frames and rigidity

Some scaffolds recur across many drugs because they display features cleanly and behave well — the privileged structures like benzodiazepines, biphenyls, or indoles. They make good landing pads for a hop because their properties are well understood. Hopping is also a chance to add conformational restriction: a rigid new core that locks the features into the bioactive pose can pay back binding entropy and boost potency.